GLP-1 and GLP-1/GIP medications may improve blood sugar, insulin resistance, A1C, cholesterol, blood pressure, fatty liver disease, sleep apnea, inflammation, and cardiovascular risk in appropriate patients
Hippocampal GLP-1 receptors influence food intake, meal size, and effort-based responding for food through volume transmission
Although Gly 2 affects GLP-1 activity to some extent, overall, exenatide shows better activity than natural GLP-1
Beta-oxidation is the metabolic pathway for using fat deposits as an energy source
Meal timing and retatrutide: before food, after food, or does it matter
These observations support continued investigation into how amylin receptor agonists affect metabolic regulation at a mechanistic level